PubRank

Andreas Kurtz

Author PubWeight™ 38.36‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Histone deacetylase controls adult stem cell aging by balancing the expression of polycomb genes and jumonji domain containing 3. Cell Mol Life Sci 2010 1.25
2 Human embryonic stem cell lines and their use in international research. Stem Cells 2010 1.25
3 Mesenchymal stem cells for cardiac cell therapy. Hum Gene Ther 2011 1.24
4 Current state of human embryonic stem cell research: an overview of cell lines and their use in experimental work. Stem Cells 2006 1.21
5 Size exclusion limits and lateral heterogeneity of the stomatal foliar uptake pathway for aqueous solutes and water-suspended nanoparticles. Physiol Plant 2008 1.19
6 Oncolytic HSV armed with platelet factor 4, an antiangiogenic agent, shows enhanced efficacy. Mol Ther 2006 1.09
7 Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors. Clin Cancer Res 2006 1.09
8 Preliminary evaluation of the CellFinder literature curation pipeline for gene expression in kidney cells and anatomical parts. Database (Oxford) 2013 0.99
9 Circulating growth factor levels are associated with tumorigenesis in neurofibromatosis type 1. Clin Cancer Res 2004 0.97
10 Concerted regulation of CD34 and CD105 accompanies mesenchymal stromal cell derivation from human adventitial stromal cell. Stem Cells Dev 2012 0.96
11 Systemically administered human bone marrow-derived mesenchymal stem home into peripheral organs but do not induce neuroprotective effects in the MCAo-mouse model for cerebral ischemia. Neurosci Lett 2012 0.93
12 Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis. PLoS One 2012 0.92
13 Isolation and characterization of fenamiphos degrading bacteria. Biodegradation 2010 0.90
14 Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors. BMC Med 2013 0.88
15 Ral overactivation in malignant peripheral nerve sheath tumors. Mol Cell Biol 2009 0.88
16 CELDA -- an ontology for the comprehensive representation of cells in complex systems. BMC Bioinformatics 2013 0.87
17 Signal therapy of NF1-deficient tumor xenograft in mice by the anti-PAK1 drug FK228. Cancer Biol Ther 2005 0.87
18 CellFinder: a cell data repository. Nucleic Acids Res 2013 0.87
19 First evaluation of the European hESCreg. Nat Biotechnol 2008 0.87
20 Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model. J Neurooncol 2009 0.86
21 Additional considerations relevant to meta-analyses of hESC publication data. Cell Stem Cell 2008 0.86
22 Ras signaling influences permissiveness of malignant peripheral nerve sheath tumor cells to oncolytic herpes. Am J Pathol 2008 0.85
23 Impaired Pten expression in human malignant peripheral nerve sheath tumours. PLoS One 2012 0.84
24 Identification of diagnostic serum protein profiles of glioblastoma patients. J Neurooncol 2010 0.84
25 HMGA2 regulates the in vitro aging and proliferation of human umbilical cord blood-derived stromal cells through the mTOR/p70S6K signaling pathway. Stem Cell Res 2012 0.84
26 Cancer stem cell-like cells derived from malignant peripheral nerve sheath tumors. PLoS One 2011 0.83
27 Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafety. J Immunother 2007 0.83
28 Human adipose-derived mesenchymal stem cells improve motor functions and are neuroprotective in the 6-hydroxydopamine-rat model for Parkinson's disease when cultured in monolayer cultures but suppress hippocampal neurogenesis and hippocampal memory function when cultured in spheroids. Stem Cell Rev 2015 0.82
29 Somatic mitochondrial mutations in pilocytic astrocytoma. Cancer Genet Cytogenet 2009 0.82
30 Sulindac derivatives inhibit cell growth and induce apoptosis in primary cells from malignant peripheral nerve sheath tumors of NF1-patients. Cancer Cell Int 2004 0.82
31 Overexpression of Midkine in malignant peripheral nerve sheath tumor cells inhibits apoptosis and increases angiogenic potency. Int J Oncol 2005 0.82
32 Cardioprotection by placenta-derived stromal cells in a murine myocardial infarction model. J Surg Res 2013 0.80
33 Scope and impact of international research in human pluripotent stem cells. Stem Cell Rev 2012 0.80
34 Using ontologies to study cell transitions. J Biomed Semantics 2013 0.79
35 Controlling major cellular processes of human mesenchymal stem cells using microwell structures. Adv Healthc Mater 2014 0.79
36 Cord blood mesenchymal stromal cell-conditioned medium protects endothelial cells via STAT3 signaling. Cell Physiol Biochem 2014 0.79
37 Impact of heart failure on the behavior of human neonatal stem cells in vitro. J Transl Med 2013 0.79
38 Serum levels of Midkine in children and adolescents without malignant disease. Pediatr Int 2009 0.78
39 Effects of pigment epithelium derived factor (PEDF) on malignant peripheral nerve sheath tumours (MPNSTs). J Neurooncol 2013 0.77
40 Increased midkine serum levels in pediatric embryonal tumor patients. J Pediatr Hematol Oncol 2009 0.77
41 Medulloblastoma harbor somatic mitochondrial DNA mutations in the D-loop region. J Pediatr Hematol Oncol 2010 0.77
42 Integration of immunological aspects in the European Human Embryonic Stem Cell Registry. Eur J Immunol 2008 0.76
43 Differential modulation of malignant peripheral nerve sheath tumor growth by omega-3 and omega-6 fatty acids. Oncogene 2005 0.76